+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pain Patch Market By Product Type, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 374 Pages
  • March 2023
  • Region: Global
  • Allied Market Research
  • ID: 5835692

The Pain Patches Market was valued for $4.80 Billion in 2021 and is estimated to reach $7.33 Billion by 2031, exhibiting a CAGR of 4.3% from 2022 to 2031.

Pain patches are a transdermal method of pain relief that involves the application of medication to the skin, where it is absorbed into the bloodstream through the skin. These patches are designed to provide continuous, controlled release of medication over a period of time, which can help manage pain effectively. They are typically used for chronic pain conditions that require ongoing treatment, such as arthritis, back pain, and neuropathic pain. The medication can be either an opioid, such as fentanyl or buprenorphine, or a non-opioid, such as lidocaine or diclofenac. They are available as over the counter (OTC) products while most of these are available through prescription only. 

The driving factors for the pain patch market are an increase in the geriatric population, a rise in the usage of pain patches and an increase in the prevalence of chronic pain cases. For instance, according to U.S. Pain Foundation 2022 report, every year 50 million people suffer from chronic pain. Thus, the rise in the prevalence of chronic pain cases is expected to drive the growth of the market. In addition, the geriatric population is majorly prone to suffer from joint pain, neuropathic pain and other chronic pain conditions. Thus, the rise in the geriatric population potentially drives the market growth. 

Furthermore, an increase in awareness associated with advanced methods for pain management and the availability of OTC pain patch products such as methyl salicylate and nitroglycerin are predicted to boost the growth of the market. In addition, a rise in advancement in patch technology is anticipated to boost the market growth. Furthermore, many key players have adopted key strategies such as collaboration, business expansion, or alliance to increase their market presence in the global pain patch market. For instance, in August 2022, Sorrento Therapeutics Inc. announced that ZTlido (lidocaine topical system) will be added to one of the largest National Pharmacy Benefit Managers (PBMs) and a national health plan - thereby expanding coverage to 30 million lives. Thus, such business expansions are expected to drive the growth of the market.     

However, factors such as the availability of alternative treatments such as acupuncture, physical therapy, and chiropractic care are projected to restrain the growth of the pain patch market. In addition, stringent government regulations associated with the manufacturing and marketing of opioid-containing pain patches is expected to hamper the growth of the market. 

The pain patch market is segmented into therapeutic class, type, distribution channel, and region. On the basis of therapeutic class, the market is bifurcated into non-opioids and opioids. The non-opioid segment is further categorized into nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, lidocaine and others. The opioid segment is further categorized into buprenorphine and fentanyl. On the basis of type, the market is bifurcated into prescription medicines and OTC medicines. On the basis of distribution channels, the market is segregated into hospital pharmacies, drug stores and retail pharmacies and online providers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global pain patch market are NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sorrento Therapeutics Inc., Hisamitsu Pharmaceutical Co.,Inc., Endo International plc., Purdue Pharma L.P., Amneal Pharmaceuticals LLC, and Grunenthal.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pain patch market analysis from 2021 to 2031 to identify the prevailing pain patch market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • An in-depth analysis of the pain patch market segmentation assists in determining the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes an analysis of the regional as well as global pain patch market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Non-Opioid Patches
  • Drugs
  • Nonsteroidal Anti-Inflammatory Drugs
  • Methyl Salicylate
  • Lidocaine
  • Others
  • Opioid Patches
  • Drugs
  • Buprenorphine
  • Fentanyl

By Type

  • Prescription Medicines
  • OTC Medicines

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • NEXGEL Advanced Hydrogel Solutions
  • Viatris Inc.
  • Johnson and Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sorrento Therapeutics Inc.
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Endo International plc.
  • Purdue Pharma L.P.
  • Amneal Pharmaceuticals LLC
  • Grunenthal

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Technological advancement in pain patches
3.4.1.2. Rise in prevalence of Chronic Pain
3.4.1.3. Rising adoption of pain patch for pain management
3.4.2. Restraints
3.4.2.1. Availability of alternate treatments
3.4.2.2. Stringent government regulations
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PAIN PATCH MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Non-Opioid Patches
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Non-Opioid Patches Pain Patch Market by Drugs
4.3. Opioid Patches
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Opioid Patches Pain Patch Market by Drugs
CHAPTER 5: PAIN PATCH MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Prescription Medicines
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. OTC Medicines
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital Pharmacies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Drug Stores and Retail Pharmacies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Online Providers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PAIN PATCH MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Type
7.2.4. Market size and forecast, by Distribution Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product Type
7.2.5.1.3. Market size and forecast, by Type
7.2.5.1.4. Market size and forecast, by Distribution Channel
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product Type
7.2.5.2.3. Market size and forecast, by Type
7.2.5.2.4. Market size and forecast, by Distribution Channel
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product Type
7.2.5.3.3. Market size and forecast, by Type
7.2.5.3.4. Market size and forecast, by Distribution Channel
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Type
7.3.4. Market size and forecast, by Distribution Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product Type
7.3.5.1.3. Market size and forecast, by Type
7.3.5.1.4. Market size and forecast, by Distribution Channel
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product Type
7.3.5.2.3. Market size and forecast, by Type
7.3.5.2.4. Market size and forecast, by Distribution Channel
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product Type
7.3.5.3.3. Market size and forecast, by Type
7.3.5.3.4. Market size and forecast, by Distribution Channel
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product Type
7.3.5.4.3. Market size and forecast, by Type
7.3.5.4.4. Market size and forecast, by Distribution Channel
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product Type
7.3.5.5.3. Market size and forecast, by Type
7.3.5.5.4. Market size and forecast, by Distribution Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product Type
7.3.5.6.3. Market size and forecast, by Type
7.3.5.6.4. Market size and forecast, by Distribution Channel
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Type
7.4.4. Market size and forecast, by Distribution Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product Type
7.4.5.1.3. Market size and forecast, by Type
7.4.5.1.4. Market size and forecast, by Distribution Channel
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product Type
7.4.5.2.3. Market size and forecast, by Type
7.4.5.2.4. Market size and forecast, by Distribution Channel
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product Type
7.4.5.3.3. Market size and forecast, by Type
7.4.5.3.4. Market size and forecast, by Distribution Channel
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product Type
7.4.5.4.3. Market size and forecast, by Type
7.4.5.4.4. Market size and forecast, by Distribution Channel
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product Type
7.4.5.5.3. Market size and forecast, by Type
7.4.5.5.4. Market size and forecast, by Distribution Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product Type
7.4.5.6.3. Market size and forecast, by Type
7.4.5.6.4. Market size and forecast, by Distribution Channel
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Type
7.5.4. Market size and forecast, by Distribution Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product Type
7.5.5.1.3. Market size and forecast, by Type
7.5.5.1.4. Market size and forecast, by Distribution Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product Type
7.5.5.2.3. Market size and forecast, by Type
7.5.5.2.4. Market size and forecast, by Distribution Channel
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product Type
7.5.5.3.3. Market size and forecast, by Type
7.5.5.3.4. Market size and forecast, by Distribution Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product Type
7.5.5.4.3. Market size and forecast, by Type
7.5.5.4.4. Market size and forecast, by Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Viatris Inc.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Johnson and Johnson
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Teva Pharmaceutical Industries Ltd.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Hisamitsu Pharmaceutical Co.,Inc.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Endo International plc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. NEXGEL Advanced Hydrogel Solutions
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Purdue Pharma L.P.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Sorrento Therapeutics Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Key strategic moves and developments
9.9. Amneal Pharmaceuticals LLC
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Grunenthal
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 02. PAIN PATCH MARKET FOR NON-OPIOID PATCHES, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GLOBAL NON-OPIOID PATCHES PAIN PATCH MARKET, BY DRUGS, 2021-2031 ($MILLION)
TABLE 04. PAIN PATCH MARKET FOR OPIOID PATCHES, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL OPIOID PATCHES PAIN PATCH MARKET, BY DRUGS, 2021-2031 ($MILLION)
TABLE 06. GLOBAL PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 07. PAIN PATCH MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2021-2031 ($MILLION)
TABLE 08. PAIN PATCH MARKET FOR OTC MEDICINES, BY REGION, 2021-2031 ($MILLION)
TABLE 09. GLOBAL PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 10. PAIN PATCH MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 11. PAIN PATCH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. PAIN PATCH MARKET FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. PAIN PATCH MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 14. NORTH AMERICA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. U.S. PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 19. U.S. PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 20. U.S. PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 21. CANADA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 22. CANADA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 23. CANADA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 24. MEXICO PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 25. MEXICO PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 26. MEXICO PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 27. EUROPE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 28. EUROPE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. EUROPE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 30. EUROPE PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. GERMANY PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 32. GERMANY PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 33. GERMANY PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 34. FRANCE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 35. FRANCE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 36. FRANCE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 37. UK PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 38. UK PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 39. UK PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 40. ITALY PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 41. ITALY PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 42. ITALY PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 43. SPAIN PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 44. SPAIN PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 45. SPAIN PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 46. REST OF EUROPE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 47. REST OF EUROPE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 49. ASIA-PACIFIC PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 50. ASIA-PACIFIC PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. JAPAN PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 54. JAPAN PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 55. JAPAN PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 56. CHINA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 57. CHINA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. CHINA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 59. INDIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 60. INDIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. INDIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 62. AUSTRALIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 63. AUSTRALIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. AUSTRALIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 65. SOUTH KOREA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. SOUTH KOREA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. LAMEA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 72. LAMEA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 73. LAMEA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 74. LAMEA PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 75. BRAZIL PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 76. BRAZIL PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 77. BRAZIL PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 78. SAUDI ARABIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 79. SAUDI ARABIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 80. SAUDI ARABIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 81. SOUTH AFRICA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 82. SOUTH AFRICA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 83. SOUTH AFRICA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 84. REST OF LAMEA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 85. REST OF LAMEA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 86. REST OF LAMEA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 87. VIATRIS INC.: KEY EXECUTIVES
TABLE 88. VIATRIS INC.: COMPANY SNAPSHOT
TABLE 89. VIATRIS INC.: PRODUCT SEGMENTS
TABLE 90. VIATRIS INC.: PRODUCT PORTFOLIO
TABLE 91. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 92. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 93. JOHNSON AND JOHNSON: PRODUCT SEGMENTS
TABLE 94. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 95. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 96. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 97. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SEGMENTS
TABLE 98. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 99. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIES
TABLE 100. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY EXECUTIVES
TABLE 101. HISAMITSU PHARMACEUTICAL CO.,INC.: COMPANY SNAPSHOT
TABLE 102. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT SEGMENTS
TABLE 103. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT PORTFOLIO
TABLE 104. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY STRATEGIES
TABLE 105. ENDO INTERNATIONAL PLC.: KEY EXECUTIVES
TABLE 106. ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT
TABLE 107. ENDO INTERNATIONAL PLC.: PRODUCT SEGMENTS
TABLE 108. ENDO INTERNATIONAL PLC.: PRODUCT PORTFOLIO
TABLE 109. NEXGEL ADVANCED HYDROGEL SOLUTIONS: KEY EXECUTIVES
TABLE 110. NEXGEL ADVANCED HYDROGEL SOLUTIONS: COMPANY SNAPSHOT
TABLE 111. NEXGEL ADVANCED HYDROGEL SOLUTIONS: PRODUCT SEGMENTS
TABLE 112. NEXGEL ADVANCED HYDROGEL SOLUTIONS: PRODUCT PORTFOLIO
TABLE 113. PURDUE PHARMA L.P.: KEY EXECUTIVES
TABLE 114. PURDUE PHARMA L.P.: COMPANY SNAPSHOT
TABLE 115. PURDUE PHARMA L.P.: PRODUCT SEGMENTS
TABLE 116. PURDUE PHARMA L.P.: PRODUCT PORTFOLIO
TABLE 117. SORRENTO THERAPEUTICS INC.: KEY EXECUTIVES
TABLE 118. SORRENTO THERAPEUTICS INC.: COMPANY SNAPSHOT
TABLE 119. SORRENTO THERAPEUTICS INC.: PRODUCT SEGMENTS
TABLE 120. SORRENTO THERAPEUTICS INC.: PRODUCT PORTFOLIO
TABLE 121. SORRENTO THERAPEUTICS INC.: KEY STRATEGIES
TABLE 122. AMNEAL PHARMACEUTICALS LLC: KEY EXECUTIVES
TABLE 123. AMNEAL PHARMACEUTICALS LLC: COMPANY SNAPSHOT
TABLE 124. AMNEAL PHARMACEUTICALS LLC: PRODUCT SEGMENTS
TABLE 125. AMNEAL PHARMACEUTICALS LLC: PRODUCT PORTFOLIO
TABLE 126. AMNEAL PHARMACEUTICALS LLC: KEY STRATEGIES
TABLE 127. GRUNENTHAL: KEY EXECUTIVES
TABLE 128. GRUNENTHAL: COMPANY SNAPSHOT
TABLE 129. GRUNENTHAL: PRODUCT SEGMENTS
TABLE 130. GRUNENTHAL: PRODUCT PORTFOLIO
TABLE 131. GRUNENTHAL: KEY STRATEGIES
List of Figures
FIGURE 01. PAIN PATCH MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF PAIN PATCH MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN PAIN PATCH MARKET (2022-2031)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPAIN PATCH MARKET
FIGURE 10. PAIN PATCH MARKET, BY PRODUCT TYPE, 2021(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR NON-OPIOID PATCHES, BY COUNTRY 2021 AND 2031(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR OPIOID PATCHES, BY COUNTRY 2021 AND 2031(%)
FIGURE 13. PAIN PATCH MARKET, BY TYPE, 2021(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY 2021 AND 2031(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR OTC MEDICINES, BY COUNTRY 2021 AND 2031(%)
FIGURE 16. PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 20. PAIN PATCH MARKET BY REGION, 2021
FIGURE 21. U.S. PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 22. CANADA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 23. MEXICO PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 24. GERMANY PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 25. FRANCE PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 26. UK PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 27. ITALY PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 28. SPAIN PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 29. REST OF EUROPE PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 30. JAPAN PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 31. CHINA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 32. INDIA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 33. AUSTRALIA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 34. SOUTH KOREA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 36. BRAZIL PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 37. SAUDI ARABIA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 38. SOUTH AFRICA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 39. REST OF LAMEA PAIN PATCH MARKET, 2021-2031 ($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: PAIN PATCH MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2021
FIGURE 47. VIATRIS INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 48. VIATRIS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 49. JOHNSON AND JOHNSON: SALES REVENUE, 2019-2021 ($MILLION)
FIGURE 50. JOHNSON AND JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 51. JOHNSON AND JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 52. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 53. TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 54. HISAMITSU PHARMACEUTICAL CO.,INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 55. ENDO INTERNATIONAL PLC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 56. ENDO INTERNATIONAL PLC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 57. AMNEAL PHARMACEUTICALS LLC: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 58. AMNEAL PHARMACEUTICALS LLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 59. GRUNENTHAL: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 60. GRUNENTHAL: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 61. GRUNENTHAL: REVENUE SHARE BY REGION, 2021 (%)

Companies Mentioned

  • NEXGEL Advanced Hydrogel Solutions
  • Viatris Inc.
  • Johnson and Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sorrento Therapeutics Inc.
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Endo International plc.
  • Purdue Pharma L.P.
  • Amneal Pharmaceuticals LLC
  • Grunenthal

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...